Literature DB >> 18370929

Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence.

Bogumil Zelent1, Stella Odili, Carol Buettger, Chiyo Shiota, Joseph Grimsby, Rebecca Taub, Mark A Magnuson, Jane M Vanderkooi, Franz M Matschinsky.   

Abstract

Tryptophan fluorescence was used to study GK (glucokinase), an enzyme that plays a prominent role in glucose homoeostasis which, when inactivated or activated by mutations, causes diabetes mellitus or hypoglycaemia in humans. GK has three tryptophan residues, and binding of D-glucose increases their fluorescence. To assess the contribution of individual tryptophan residues to this effect, we generated GST-GK [GK conjugated to GST (glutathione transferase)] and also pure GK with one, two or three of the tryptophan residues of GK replaced with other amino acids (i.e. W99C, W99R, W167A, W167F, W257F, W99R/W167F, W99R/W257F, W167F/W257F and W99R/W167F/W257F). Enzyme kinetics, binding constants for glucose and several other sugars and fluorescence quantum yields (varphi) were determined and compared with those of wild-type GK retaining its three tryptophan residues. Replacement of all three tryptophan residues resulted in an enzyme that retained all characteristic features of GK, thereby demonstrating the unique usefulness of tryptophan fluorescence as an indicator of GK conformation. Curves of glucose binding to wild-type and mutant GK or GST-GK were hyperbolic, whereas catalysis of wild-type and most mutants exhibited co-operativity with D-glucose. Binding studies showed the following order of affinities for the enzyme variants: N-acetyl-D-glucosamine>D-glucose>D-mannose>D-mannoheptulose>2-deoxy-D-glucose>>L-glucose. GK activators increased sugar binding of most enzymes, but not of the mutants Y214A/V452A and C252Y. Contributions to the fluorescence increase from Trp(99) and Trp(167) were large compared with that from Trp(257) and are probably based on distinct mechanisms. The average quantum efficiency of tryptophan fluorescence in the basal and glucose-bound state was modified by activating (Y214A/V452A) or inactivating (C213R and C252Y) mutations and was interpreted as a manifestation of distinct conformational states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370929     DOI: 10.1042/BJ20071718

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Thermal stability of glucokinase (GK) as influenced by the substrate glucose, an allosteric glucokinase activator drug (GKA) and the osmolytes glycerol and urea.

Authors:  B Zelent; C Buettger; J Grimsby; R Sarabu; J M Vanderkooi; A J Wand; F M Matschinsky
Journal:  Biochim Biophys Acta       Date:  2012-03-16

2.  Mutational analysis of allosteric activation and inhibition of glucokinase.

Authors:  Bogumil Zelent; Stella Odili; Carol Buettger; Dorothy K Zelent; Pan Chen; Deborah Fenner; Joseph Bass; Charles Stanley; Monique Laberge; Jane M Vanderkooi; Ramakanth Sarabu; Joseph Grimsby; Franz M Matschinsky
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

3.  Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels.

Authors:  Michele L Markwardt; Andongfac Nkobena; Shi-Ying Ding; Mark A Rizzo
Journal:  Mol Endocrinol       Date:  2012-07-06

4.  GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation.

Authors:  Maria Negahdar; Ingvild Aukrust; Bente B Johansson; Janne Molnes; Anders Molven; Franz M Matschinsky; Oddmund Søvik; Rohit N Kulkarni; Torgeir Flatmark; Pål Rasmus Njølstad; Lise Bjørkhaug
Journal:  Biochim Biophys Acta       Date:  2012-07-20

5.  Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease.

Authors:  Shawn M Sternisha; A Carl Whittington; Juliana A Martinez Fiesco; Carol Porter; Malcolm M McCray; Timothy Logan; Cristina Olivieri; Gianluigi Veglia; Peter J Steinbach; Brian G Miller
Journal:  Biophys J       Date:  2020-01-14       Impact factor: 4.033

Review 6.  Homotropic allosteric regulation in monomeric mammalian glucokinase.

Authors:  Mioara Larion; Brian G Miller
Journal:  Arch Biochem Biophys       Date:  2011-11-15       Impact factor: 4.013

7.  Tryptophan Fluorescence Yields and Lifetimes as a Probe of Conformational Changes in Human Glucokinase.

Authors:  Bogumil Zelent; Chris Bialas; Ignacy Gryczynski; Pan Chen; Rahul Chib; Karina Lewerissa; Maria G Corradini; Richard D Ludescher; Jane M Vanderkooi; Franz M Matschinsky
Journal:  J Fluoresc       Date:  2017-04-22       Impact factor: 2.217

Review 8.  Assessing the potential of glucokinase activators in diabetes therapy.

Authors:  Franz M Matschinsky
Journal:  Nat Rev Drug Discov       Date:  2009-04-17       Impact factor: 84.694

9.  Glucokinase activators for diabetes therapy: May 2010 status report.

Authors:  Franz M Matschinsky; Bogumil Zelent; Nicolai Doliba; Changhong Li; Jane M Vanderkooi; Ali Naji; Ramakanth Sarabu; Joseph Grimsby
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

10.  Lys169 of human glucokinase is a determinant for glucose phosphorylation: implication for the atomic mechanism of glucokinase catalysis.

Authors:  Jian Zhang; Chenjing Li; Ting Shi; Kaixian Chen; Xu Shen; Hualiang Jiang
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.